Drug data last refreshed 3h ago · AI intelligence enriched 6h ago
ADVIL (ibuprofen sodium) is an oral tablet nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and inflammation management. It is a small-molecule formulation of ibuprofen designed for rapid absorption and faster onset of action compared to standard ibuprofen. The drug works by inhibiting cyclooxygenase enzymes to reduce prostaglandin production.
Peak lifecycle stage with 30% competitive pressure indicates a mature, stable commercial franchise requiring defensive market strategies and efficiency-focused team management.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects
Ibuprofen Sodium Tension Headache Study
Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers.
Worked on ADVIL at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on ADVIL at peak lifecycle offers exposure to mature-market commercial strategy, competitive pricing, and brand defense; limited growth upside but solid foundation for retail/OTC channel expertise and consumer marketing. Career trajectory will focus on operational efficiency, market share optimization, and defensive positioning rather than launch momentum.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo